Niterra Leads $10M Growth Funding Round for Imbed Biosciences
Round will fuel growth, cementing Imbed’s position as a leader in advanced wound care Niterra is participating in $10M convertible debt financing for Imbed Biosciences, Inc. (Imbed), a tissue engineering company developing advanced biomaterials for…
Read More